Rana Quraishi

Company: Isoprene Pharmaceuticals

Job title: Chief Executive Officer

Seminars:

Driving Forward Molecular Glues – Pre-Clinical & Clinical Data with Lead Molecular Glue Degraders 4:00 pm

Advancing small molecule degraders D7 for TNBC and 433Beta for prostate cancers – tumor regression in animal models Uncovering the mechanism of molecular glue induced degradation of Androgen Receptor and MNK1/2 Showcasing the results from a Phase II human clinical trial in PDAC with a molecular glue New CompanyRead more

day: Conference Day Two